Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-02-27, Stock:NVO, The news for the past five days is as follows:
2018-02-20: NEWS1: The Zacks Analyst Blog Highlights: Nordisk, TJX, Cigna, Regeneron and ArcelorMittal.NEWS2: The Zacks Analyst Blog Highlights: Nordisk, TJX, Cigna, Regeneron and ArcelorMittal.NEWS3: The Zacks Analyst Blog Highlights: Nordisk, TJX, Cigna, Regeneron and ArcelorMittal.
2018-02-21: NEWS1: Novo Nordisk gets nod from U.S. drug purchaser for new diabetes hope.NEWS2: Eurozone Beats United States Again: 5 Hot Stock Picks.NEWS3: Eurozone Beats United States Again: 5 Hot Stock Picks.NEWS4: Analysts Expect FTLB To Hit $25.NEWS5: Analysts Expect FTLB To Hit $25.NEWS6: Eurozone Beats United States Again: 5 Hot Stock Picks.
2018-02-22: NEWS1: A Look at Eli Lilly’s 4Q17 Revenue.NEWS2: European ADRs Move Higher in Thursday Trading.NEWS3: European ADRs Move Higher in Thursday Trading.NEWS4: Health Care Sector Update for 02/22/2018: SGMO, GILD, CLVS, NVO, NVS, BKD.NEWS5: Health Care Sector Update for 02/22/2018: SGMO, GILD, CLVS, NVO, NVS, BKD.NEWS6: Novo Nordisk successfully kicks off final-stage trials for first diabetes pill.
2018-02-23: NEWS1: Pharma Stock Roundup: AZN's Imfinzi Gets 2nd FDA Nod, MRK to Buy Australian Firm.NEWS2: Pharma Stock Roundup: AZN's Imfinzi Gets 2nd FDA Nod, MRK to Buy Australian Firm.NEWS3: Today’s Biotech Movers: Sangamo Therapeutics, Inc. (NASDAQ:SGMO) And Novo Nordisk A/S (ADR) (NYSE:NVO).
2018-02-26: NEWS1: What’s Expected for Novo Nordisk’s Net Income Margin in 2018.NEWS2: Novo Nordisk Expected to Report Flat Revenue in 2018.NEWS3: Analysts’ Recommendations for Novo Nordisk and Peers in 2018.

Answer: Decrease